Hyperlipidemia, unspecified, is a clinical condition characterized by abnormally elevated levels of lipids (fats) in the blood, including cholesterol and triglycerides. It is a major contributor to the development of [Atherosclerotic Heart Disease](/icd10/i25-1) and is often identified during routine screening since the condition itself typically presents no outward symptoms. Because E78.5 is an 'unspecified' code, it is frequently used when a provider has not yet differentiated whether the elevation is predominantly cholesterol-based or triglyceride-based. Chronic elevation of blood lipids can lead to the formation of arterial plaques, increasing the risk of cardiovascular events such as myocardial infarction or stroke. Management typically involves lifestyle modifications, including diet and exercise, and pharmacotherapy with statins or fibrates. Clinicians should screen for secondary causes like [Type 2 Diabetes Mellitus](/icd10/e11-9) or [Hypothyroidism](/icd10/e03-9), as these metabolic disorders frequently exacerbate lipid imbalances.